Kinfo
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc.

INBSNASDAQHealthcare·US · USD
$1.97
+0.21 (+11.93%)
Prices as of November 6, 2026 · market closed

Price

Key statistics

Valuation
Market cap6.53M USD
Enterprise value2.79M USD
Trailing P/E10.08
Forward P/E5.03
PEG ratio5.03
Price / sales1.38
Price / book0.93
Profitability
Gross margin46.83%
Operating margin-345.98%
Profit margin-294.91%
Return on assets-76.20%
Return on equity-307.69%
Income (TTM)
Revenue4.22M USD
Gross profit2.05M USD
EBITDA-11.15M USD
Net income-12.43M USD
Diluted EPS-$8.44
Rev. growth (YoY)35.80%
Balance sheet
Total cash4.14M USD
Total debt1.82M USD
Debt / equity34.38
Current ratio1.44
Book value / share$1.90
Cash flow (TTM)
Operating cash flow-11.93M USD
Levered free cash flow-6.72M USD
Shares & price
Shares outstanding2.91M
Float2.94M
Held by institutions5.81%
Beta4.49
50-day MA$1.83
200-day MA$2.95
52-week high$24.90
52-week low$1.35
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-19-1.58-0.90+43.04%2026-06-161.651.67+1.21%2026-05-131.40-1.80−228.57%2026-04-140.440.48+9.09%2025-12-17-0.360.10+127.78%
About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. is a medical technology company focused on delivering rapid, non-invasive testing and screening solutions. The company’s current offerings center on the Intelligent Fingerprinting platform, which uses fingerprint sweat analysis with a portable handheld reader and single-use cartridge to support drug screening in workplace and other safety-critical settings. It also develops a biosensor platform aimed at diagnostic and monitoring applications, including clinical chemistry, immunology, hormones, tumor markers, and nucleic acid testing. Intelligent Bio Solutions serves customers across the United States, the United Kingdom, Asia Pacific, and other international markets, positioning itself in the broader medical diagnostics and life sciences sector. Headquartered in New York, the company concentrates on tools that combine portability, speed, and non-invasive sample collection for practical use in professional testing environments.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Harry Simeonidis
Employees
53
Headquarters
New York, NY, United States
Website
ibs.inc

Frequently asked questions about Intelligent Bio Solutions Inc.